Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Current Taxes (2019 - 2022)

Nurix Therapeutics (NRIX) has disclosed Current Taxes for 4 consecutive years, with $41000.0 as the latest value for Q3 2022.

  • Quarterly Current Taxes rose 10.81% to $41000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $41000.0 through Aug 2022, up 10.81% year-over-year, with the annual reading at $75000.0 for FY2021, 1.35% up from the prior year.
  • Current Taxes for Q3 2022 was $41000.0 at Nurix Therapeutics, up from $26000.0 in the prior quarter.
  • The five-year high for Current Taxes was $325000.0 in Q1 2021, with the low at $26000.0 in Q2 2022.
  • Average Current Taxes over 4 years is $77555.6, with a median of $41000.0 recorded in 2022.
  • The sharpest move saw Current Taxes skyrocketed 124.24% in 2020, then tumbled 83.69% in 2022.
  • Over 4 years, Current Taxes stood at $33000.0 in 2019, then soared by 124.24% to $74000.0 in 2020, then rose by 1.35% to $75000.0 in 2021, then tumbled by 45.33% to $41000.0 in 2022.
  • According to Business Quant data, Current Taxes over the past three periods came in at $41000.0, $26000.0, and $53000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.